During the 8th annual Microbiome Movement Drug Development Europe, held in Barcelona (Spain), Microbiomepost sat down with Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, to discuss the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex respiratory diseases.